Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WH4J
|
|||
| Former ID |
DNC008967
|
|||
| Drug Name |
Isosorbide-2-(propylcarbamate)-5-mononitrate
|
|||
| Synonyms |
CHEMBL494519; Isosorbide-2-(propylcarbamate)-5-mononitrate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H16N2O7
|
|||
| Canonical SMILES |
CCCNC(=O)OC1COC2C1OCC2O[N+](=O)[O-]
|
|||
| InChI |
1S/C10H16N2O7/c1-2-3-11-10(13)18-6-4-16-9-7(19-12(14)15)5-17-8(6)9/h6-9H,2-5H2,1H3,(H,11,13)/t6-,7+,8+,9+/m0/s1
|
|||
| InChIKey |
HZZGTUOWJWTZKT-JQCXWYLXSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| WikiPathways | Irinotecan Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors. J Med Chem. 2008 Oct 23;51(20):6400-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.